Asit Kumar Chakraborty
Associate Professor of Biochemistry, Department of Biochemistry, Oriental Institute of Science and Technology, Vidyasagar University, Midnapore, West Bengal, India
*Corresponding Author:Asit Kumar Chakraborty, Associate Professor of Biochemistry, Department of Biochemistry, Oriental Institute of Science and Technology, Vidyasagar University, Midnapore, West Bengal, India.
Received: April 06, 2020; Published: May 04, 2020
COVID-19 infections are rapidly spreading worldwide with more than 100000 death and thus understanding the molecular mechanism of tropism of human cells is an urgent need for drug design. We have described here a bioinformatics approach to predict the functional aspects of non-structural nsp16 protein of Corona virus. The COVID-19 7096 AA large polyprotein was degraded into sixteen proteins and last nsp16 protein was found an RlmE type rRNA Methyltransferase. Nsp16 has no similarity to bacterial RlmABCD but has 25 percent similarity to the bacterial RlmE MTase protein which methylates the U2551 2-hydroxy group of Ribose. The nsp16 proteins of different corona viruses like Covid-19, bat-coronavirus, SARS and MERS have strong homology. Mrm2 and Dim1 like yeast and mammalian rRNA methyltransferases have 26-33 percent homologies but not with 2’-O-capping MTase as reported previously. Rrp8 MTases also has no similarity to nsp16. We postulated that mitochondrial rRNA methylation of bronchial cells were mediated by the nsp16 protein causing inhibition of protein synthesis due to poor assembly of aminoacyl-tRNA or mRNA and peptidyl transferase at the PTC. This is one of the new molecular mechanism of corona virus cellular tropism and different than ACE-2 mediated blockage of cellular signalling to inhibit aldesterone biosynthesis with abnormal Na+ ions in cells. We also designed primers based on nsp16 cDNA sequence (nt 20659-21552, accession no MT121215) specific for Covid-19 diagnosis by RT-PCR. Antisense and ribozyme against Nsp16 may be another molecular approach to stop Coronavirus translation using nano-carrier drug delivery. Whereas phyto-chemicals from Indian medicinal plants may be studied to stop functions of Nsp16 RlmE Methyltransferase as another therapeutic approach against Coronavirus pathogenesis.
Keywords:Covid-19; rlmE MTase; New Drug Target; Corona Diagnosis; Corona Pandemic
Citation: Asit Kumar Chakraborty. “Clinical, Diagnostic and Therapeutic Implications of Coronavirus ORFab Polyprotein Associated Nsp16 Protein-A Bioinformatics Approach". Acta Scientific Medical Sciences 4.5 (2020): 97-103.
Copyright: © 2020 Asit Kumar Chakraborty. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.